论文部分内容阅读
目的深入探讨苯巴比妥对肝炎后高非结合胆红素血症的治疗效果。方法将48例肝炎后高非结合胆红素血症患者随机分为两组,治疗组24例,给予苯巴比妥治疗,对照组24例给予保肝退黄治疗,半月为一疗程,连用1～2个疗程后.观察肝功及血清总胆红素恢复情况。结果治疗组临床疗效明显优于观察组(P<0.01)。结论苯巴比妥治疗肝炎后高非结合胆红素血症,副作用少,临床疗效显著,确实值得临床应用。
Objective To investigate in depth the therapeutic effect of phenobarbital on post-hepatitis high non-conjugated bilirubin. Methods A total of 48 patients with post-hepatitis B non-conjugated hyperbilirubinemia were randomly divided into two groups. The treatment group (24 cases) was given phenobarbital and the control group (24 cases) After 1 to 2 courses of observation, liver function and serum total bilirubin recovery were observed. Results The clinical efficacy of the treatment group was significantly better than that of the observation group (P <0.01). Conclusion Phenobarbital treatment of hepatitis with high non-conjugated bilirubin, with fewer side effects, clinical efficacy is significant, indeed worthy of clinical application.